AMENDMENT #2 TO CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • May 30th, 2024 • China Pharma Holdings, Inc. • Pharmaceutical preparations
This Amendment #2 to Convertible Promissory Note (this “Amendment”) is entered into as of May 23, 2024, by and between Streeterville Capital, LLC, a Utah limited liability company (“Lender”), and China Pharma Holdings, Inc., a Nevada corporation (“Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below).
